Pantoprazole Sodium
Product Images NDC 70332-301

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 70332-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by California Pharmaceutical, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pantoprazole 30ct (Pantoprazole 30ct)

Pantoprazole Sodium Delayed-Release 40 mg Tablets, USP, containing 30 tablets per package. The label shows the active ingredient strength as 40 mg per tablet and indicates storage instructions. It is manufactured by Lannett Company, Inc. and repackaged and distributed by California Pharmaceutical, LLC. The label includes a barcode and cautions not to use if the seal is broken.*

FDA Label Image

Chemical Structure (Pantoprazole Sodium Delayed Release Tablets 1)

Chemical structure of Pantoprazole Sodium showing its molecular framework including pyridine and benzimidazole rings, with functional groups such as methoxy, difluoromethoxy, sulfinyl, and associated sodium ion and water of hydration (1.5 H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.